Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of adrenal physiology (HP:0011733)help
Parent Node:
expand
Abnormality of circulating cortisol level (HP:0011731)help
Parent Node:
expand
Adrenal overactivity (HP:0002717)help
..Starting node
..expand
Increased circulating cortisol level (HP:0003118)help
Term ID: 3118
Name: Increased circulating cortisol level
Synonym: Cushing syndrome; Hypercortisolism; Increased circulating cortisol level; Increased cortisol production
Definition: Overproduction of the hormone of cortisol by the adrenal cortex, resulting in a characteristic combination of clinical symptoms termed Cushing syndrome, with truncal obesity, a round, full face, striae atrophicae and acne, muscle weakness, and other features.
Comments:
Reference: HP:0003118
Genes and Diseases:
 
       Child Nodes:
........expandPrimary hypercorticolism (HP:0001579) help
........expandSecondary hypercorticolism (HP:0011744) help
........expandElevated serum 11-deoxycortisol (HP:0025436) help

 Sister Nodes: 
..expandHyperaldosteronism (HP:0000859) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0003118HP:0003118Increased circulating cortisol level0AIRE CL E G H326360ORPHA:3453Autoimmune polyendocrinopathy type 1HP:0040281 - Very frequent92
HP:0003118HP:0003118Increased circulating cortisol level0ARMC5 CL E G H7979825781OMIM:615954ACTH-independent macronodular adrenal hyperplasia 27
HP:0003118HP:0003118Increased circulating cortisol level0ARMC5 CL E G H7979825781ORPHA:189427Cushing syndrome due to macronodular adrenal hyperplasia7
HP:0003118HP:0003118Increased circulating cortisol level0ATRX CL E G H546886ORPHA:96253Cushing disease169
HP:0003118HP:0003118Increased circulating cortisol level0BRAF CL E G H6731097ORPHA:96253Cushing disease276
HP:0003118HP:0003118Increased circulating cortisol level0CDH23 CL E G H6407213733ORPHA:96253Cushing disease636
HP:0003118HP:0003118Increased circulating cortisol level0CDKN1A CL E G H10261784ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional2
HP:0003118HP:0003118Increased circulating cortisol level0CDKN1B CL E G H10271785ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional102
HP:0003118HP:0003118Increased circulating cortisol level0CDKN1B CL E G H10271785ORPHA:276152Multiple endocrine neoplasia type 4HP:0040283 - Occasional102
HP:0003118HP:0003118Increased circulating cortisol level0CDKN2A CL E G H10291787ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent289
HP:0003118HP:0003118Increased circulating cortisol level0CDKN2B CL E G H10301788ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional1
HP:0003118HP:0003118Increased circulating cortisol level0CDKN2C CL E G H10311789ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional
HP:0003118HP:0003118Increased circulating cortisol level0CTNNB1 CL E G H14992514ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent88
HP:0003118HP:0003118Increased circulating cortisol level0CYP11B1 CL E G H15842591OMIM:202010Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency112
HP:0003118HP:0003118Increased circulating cortisol level0CYP11B2 CL E G H15852592ORPHA:556030Early-onset familial hypoaldosteronism73
HP:0003118HP:0003118Increased circulating cortisol level0GNAS CL E G H27784392OMIM:219080ACTH-independent macronodular adrenal hyperplasia.101
HP:0003118HP:0003118Increased circulating cortisol level0GNAS CL E G H27784392ORPHA:189427Cushing syndrome due to macronodular adrenal hyperplasia101
HP:0003118HP:0003118Increased circulating cortisol level0GNAS CL E G H27784392ORPHA:562McCune-Albright syndromeHP:0040284 - Very rare101
HP:0003118HP:0003118Increased circulating cortisol level0GNAS CL E G H27784392OMIM:174800McCune-Albright syndrome, somatic, mosaic.101
HP:0003118HP:0003118Increased circulating cortisol level0HTR1A CL E G H33505286OMIM:614674Periodic fever, menstrual cycle-dependentHP:0040283 - Occasional2
HP:0003118HP:0003118Increased circulating cortisol level0KCNJ11 CL E G H37676257ORPHA:79644Autosomal recessive hyperinsulinism due to Kir6.2 deficiency127
HP:0003118HP:0003118Increased circulating cortisol level0MEN1 CL E G H42217010OMIM:131100Multiple endocrine neoplasia 1.462
HP:0003118HP:0003118Increased circulating cortisol level0MEN1 CL E G H42217010ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional462
HP:0003118HP:0003118Increased circulating cortisol level0NR3C1 CL E G H29087978ORPHA:96253Cushing disease79
HP:0003118HP:0003118Increased circulating cortisol level0NR3C1 CL E G H29087978ORPHA:786Generalized glucocorticoid resistance syndromeHP:0040281 - Very frequent79
HP:0003118HP:0003118Increased circulating cortisol level0PDE11A CL E G H509408773ORPHA:1359Carney complexHP:0040282 - Frequent13
HP:0003118HP:0003118Increased circulating cortisol level0PDE11A CL E G H509408773OMIM:610475Pigmented nodular adrenocortical disease, primary, 2.13
HP:0003118HP:0003118Increased circulating cortisol level0PDE11A CL E G H509408773ORPHA:189439Primary pigmented nodular adrenocortical disease13
HP:0003118HP:0003118Increased circulating cortisol level0PDE8B CL E G H86228794OMIM:614190Pigmented nodular adrenocortical disease, primary, 3.75
HP:0003118HP:0003118Increased circulating cortisol level0PDE8B CL E G H86228794ORPHA:189439Primary pigmented nodular adrenocortical disease75
HP:0003118HP:0003118Increased circulating cortisol level0PRKACA CL E G H55669380OMIM:615830Pigmented nodular adrenocortical disease, primary, 4.2
HP:0003118HP:0003118Increased circulating cortisol level0PRKACA CL E G H55669380ORPHA:189439Primary pigmented nodular adrenocortical disease2
HP:0003118HP:0003118Increased circulating cortisol level0PRKAR1A CL E G H55739388ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent134
HP:0003118HP:0003118Increased circulating cortisol level0PRKAR1A CL E G H55739388ORPHA:1359Carney complexHP:0040282 - Frequent134
HP:0003118HP:0003118Increased circulating cortisol level0PRKAR1A CL E G H55739388OMIM:610489Pigmented nodular adrenocortical disease, primary, 1.134
HP:0003118HP:0003118Increased circulating cortisol level0PRKAR1A CL E G H55739388ORPHA:189439Primary pigmented nodular adrenocortical disease134
HP:0003118HP:0003118Increased circulating cortisol level0RET CL E G H59799967OMIM:171400Multiple endocrine neoplasia, type IIA.572
HP:0003118HP:0003118Increased circulating cortisol level0TERT CL E G H701511730ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent238
HP:0003118HP:0003118Increased circulating cortisol level0TP53 CL E G H715711998ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent911
HP:0003118HP:0003118Increased circulating cortisol level0TP53 CL E G H715711998ORPHA:96253Cushing disease911
HP:0003118HP:0003118Increased circulating cortisol level0USP48 CL E G H8419618533ORPHA:96253Cushing disease1
HP:0003118HP:0003118Increased circulating cortisol level0USP8 CL E G H910112631ORPHA:96253Cushing disease7
HP:0003118HP:0003118Increased circulating cortisol level0ZNRF3 CL E G H8413318126ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent
HP:0003118HP:0011744Secondary hypercortisolism1 CL E G H
HP:0003118HP:0001579Primary hypercortisolism1CDKN1A CL E G H10261784ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional2
HP:0003118HP:0001579Primary hypercortisolism1CDKN1B CL E G H10271785ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional102
HP:0003118HP:0025436Elevated serum 11-deoxycortisol1CDKN2A CL E G H10291787ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent289
HP:0003118HP:0001579Primary hypercortisolism1CDKN2B CL E G H10301788ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional1
HP:0003118HP:0001579Primary hypercortisolism1CDKN2C CL E G H10311789ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional
HP:0003118HP:0025436Elevated serum 11-deoxycortisol1CTNNB1 CL E G H14992514ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent88
HP:0003118HP:0025436Elevated serum 11-deoxycortisol1CYP11B1 CL E G H15842591OMIM:202010Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency112
HP:0003118HP:0025436Elevated serum 11-deoxycortisol1CYP11B2 CL E G H15852592ORPHA:556030Early-onset familial hypoaldosteronismHP:0040282 - Frequent73
HP:0003118HP:0001579Primary hypercortisolism1GNAS CL E G H27784392OMIM:219080ACTH-independent macronodular adrenal hyperplasia.101
HP:0003118HP:0001579Primary hypercortisolism1GNAS CL E G H27784392ORPHA:562McCune-Albright syndromeHP:0040284 - Very rare101
HP:0003118HP:0001579Primary hypercortisolism1MEN1 CL E G H42217010ORPHA:652Multiple endocrine neoplasia type 1HP:0040283 - Occasional462
HP:0003118HP:0001579Primary hypercortisolism1PDE11A CL E G H509408773OMIM:610475Pigmented nodular adrenocortical disease, primary, 2.13
HP:0003118HP:0001579Primary hypercortisolism1PRKACA CL E G H55669380OMIM:615830Pigmented nodular adrenocortical disease, primary, 4.2
HP:0003118HP:0025436Elevated serum 11-deoxycortisol1PRKAR1A CL E G H55739388ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent134
HP:0003118HP:0001579Primary hypercortisolism1PRKAR1A CL E G H55739388OMIM:610489Pigmented nodular adrenocortical disease, primary, 1.134
HP:0003118HP:0025436Elevated serum 11-deoxycortisol1TERT CL E G H701511730ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent238
HP:0003118HP:0025436Elevated serum 11-deoxycortisol1TP53 CL E G H715711998ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent911
HP:0003118HP:0025436Elevated serum 11-deoxycortisol1ZNRF3 CL E G H8413318126ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent


Genes (28) :AIRE ARMC5 ATRX BRAF CDH23 CDKN1A CDKN1B CDKN2A CDKN2B CDKN2C CTNNB1 CYP11B1 CYP11B2 GNAS HTR1A KCNJ11 MEN1 NR3C1 PDE11A PDE8B PRKACA PRKAR1A RET TERT TP53 USP48 USP8 ZNRF3

Diseases (23) :ORPHA:3453 OMIM:615954 ORPHA:189427 ORPHA:96253 ORPHA:652 ORPHA:276152 ORPHA:1501 OMIM:202010 ORPHA:556030 OMIM:219080 ORPHA:562 OMIM:174800 OMIM:614674 ORPHA:79644 OMIM:131100 ORPHA:786 ORPHA:1359 OMIM:610475 ORPHA:189439 OMIM:614190 OMIM:615830 OMIM:610489 OMIM:171400
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.